CBR Biotech Strategies GmbH specializes in the development and E.U. representation for biotech, pharmaceutical and medical device companies.
CBR Biotech Strategies GmbH was founded in 2013 as a partner company of CBR International Corp., USA (founded in 2002). Both companies are owned by Jeanne Novak, Ph.D. and have more than 2 decades of experience in drug development and regulatory affairs. During the past years Jeanne Novak has built a great team of motivated international experts covering all phases of program development from concept, Phase I-IV and commercialization.
Our team has considerable experience with European regulatory representation for the biopharma and pharmaceutical industries. With a myriad of development programs including biologics, antibodies, small molecules and medical devices, CBR Biotech Strategies GmbH specializes in the preparation, compilation, and publication of submission relevant documents for the U.S. and European markets.
CBR Biotech Strategies to provide support and build systems.
We are not simply consultants, we are an extension of YOUR team in global development and strategy. We are not just regulators, we are scientists who understand what regulatory agencies require for product development and approval. Everything we do is customized to YOUR needs with regard to your stage of development, financial planning and corporate goals.
Our motivation and our aim is to offer tailored services to suit YOUR needs and to achieve YOUR fullest satisfaction.